Atle Fund Management AB Diversified Active

Location: Stockholm, Sweden

CIK: 0001381843 · Show all filings

Period: Q4 2020 (← Previous) (Next →)

Filing Date: Feb 5, 2021

Total Value: $151M (100.0% shares, 0.0% debt)

Holdings (17)

SUPN SUPERNUS PHARMACEUTICALS INC 7.7%
Value $11.7M Shares 465,000 Est. Cost $21.52 Unrealized 0.0%
CHRS COHERUS BIOSCIENCES INC 6.9%
Value $10.43M Shares 600,000 Est. Cost $17.80 Unrealized 0.0%
VTRS VIATRIS INC 6.5%
Value $9.839M Shares 525,000 Est. Cost $13.33 Unrealized 0.0%
CI CIGNA CORP NEW 6.5%
Value $9.784M Shares 47,000 Est. Cost $179.43 Unrealized 0.0%
COLL COLLEGIUM PHARMACEUTICAL INC 6.4%
Value $9.614M Shares 480,000 Est. Cost $19.53 Unrealized 0.0%
IRWD IRONWOOD PHARMACEUTICALS INC 6.3%
Value $9.511M Shares 835,000 Est. Cost $10.94 Unrealized 0.0%
UHS UNIVERSAL HLTH SVCS INC 6.2%
Value $9.35M Shares 68,000 Est. Cost $121.19 Unrealized 0.0%
ABBV ABBVIE INC 6.2%
Value $9.322M Shares 87,000 Est. Cost $78.94 Unrealized 0.0%
MCK MCKESSON CORP 6.1%
Value $9.218M Shares 53,000 Est. Cost $153.69 Unrealized +5.0%
COR AMERISOURCEBERGEN CORP 6.0%
Value $9.092M Shares 93,000 Est. Cost $89.37 Unrealized 0.0%
BMY BRISTOL-MYERS SQUIBB CO 6.0%
Value $9.056M Shares 146,000 Est. Cost $48.97 Unrealized +2.2%
CAH CARDINAL HEALTH INC 6.0%
Value $9.052M Shares 169,000 Est. Cost $46.35 Unrealized -1.7%
TEVA TEVA PHARMACEUTICAL INDS LTD 5.8%
Value $8.83M Shares 915,000 Est. Cost $9.65 Unrealized
ARAY ACCURAY INC 4.6%
Value $6.881M Shares 1,650,000 Est. Cost $3.67 Unrealized 0.0%
ANTARES PHARMA INC 4.5%
Value $6.863M Shares 1,720,000 Est. Cost $3.99 Unrealized
BIODELIVERY SCIENCES INTL IN 4.4%
Value $6.615M Shares 1,575,000 Est. Cost $4.20 Unrealized
CPRX CATALYST PHARMACEUTICALS INC 3.9%
Value $5.845M Shares 1,750,000 Est. Cost $3.36 Unrealized 0.0%